Perimenopause and mood disturbance: An update

CNS Spectrums

Volumn 6, Issue 2, 2001, Pages 167-174

  Soares, C N ^a   Cohen, L S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CONJUGATED ESTROGEN; ESTROGEN; FLUOXETINE; IMIPRAMINE; PLACEBO;

AFFECTIVE NEUROSIS; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; HORMONE DEPENDENCE; HUMAN; MENOPAUSE; META ANALYSIS; PRIORITY JOURNAL; PSYCHOBIOLOGY; REVIEW; SOCIAL PSYCHOLOGY;

EID: 0034973922     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900007926     Document Type: Review

References (70)

1. Research on menopause in the 1990s: Report of a WHO scientific group
2. The menopausal transition
3. The perimenopause and affective disorders
4. Clinical challenges of perimenopause: Consensus opinion of the North American Menopause Society
5. Menstrual cyclicity and the premenopause
6. The normal menopause transition: An overview
7. Cigarette smoking and the risk of natural menopause
8. The menopause: A signal for the future
9. Association of medically treated depression and age at natural menopause
10. Fluctuating ovarian function in perimenopausal women
11. The menopausal syndrome
12. The menopausal hot flush: Symptom reports and concomitant physiological changes
13. Hot flashes revisited
14. Hot flashes: Phenomenology, quality of life, and search for treatment options
15. Oestrogen therapy and the menopausal syndrome
16. The effect of transdermal estradiol on hormone and metabolic dynamics over a six-week period
17. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women
18. Symptom experiences of midlife women: Observations from the Seattle midlife women's health study
19. The age of menopause in the Netherlands. The statistical analysis of a survey
20. Physiology and symptoms of menopause
21. Menopause
22. Psychological well-being in the post-parental stage: Some evidence from national surveys
23. Ambiguities of aging: Japanese experience and perceptions of menopause
24. Menopause in cultural context
25. Association of diet and other lifestyle with onset of menopause in Japanese women
26. Characteristics of menopausal women seeking assistance
27. Affective symptoms in women attending a menopause clinic
28. Premenstrual syndrome and psychiatric morbidity at the menopause
29. The treatment-seeking woman at menopause
30. A longitudinal analysis of women's attitudes toward the menopause: Results from the Massachusetts women's health study
31. Depressive symptoms in the perimenopause: Prevalence, assessment, and guidelines for treatment
32. Study of symptoms in middle life with special reference to the menopause
33. Mental health among perimenopausal women attending a menopause clinic: Possible association with premenstrual clinic?
34. Psychiatric morbidity and the menopause: Survey of a gynaecological outpatient clinic
35. Relationships between psychological symptoms, somatic complaints and menopausal status
36. Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: A population-based study
37. The Manitoba Project: A re-examination of the link between menopause and depression
38. Prevalence and predictors of depressive symptoms in older premenopausal women: The Harvard study of moods and cycles
39. Menopause-related affective disorders: A justification for further study
40. The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause. A hypothesis and review of supporting data
41. Oestrogens and depression in women
42. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome
43. Estrogen, serotonin, and mood disturbance: Where is the therapeutic bridge?
44. Sex and depression in the national comorbidity survey. I: Lifetime prevalence, chronicity and recurrence
45. Relationships between premenstrual complaints and perimenopausal experiences
46. Is severity of premenstrual symptoms related to illness in the climacteric?
47. Mood, hormones and menopause
48. Platelet serotonin content and plasma tryptophan in peri- and postmenopausal women: Variations with plasma oestrogen levels and depressive symptoms
49. Menopause, mood and hormone replacement therapy: Methódological issues
50. A pilot trial assessing the efficacy of paroxetine hydrochloride (paxil) in controlling hot flashes in breast cancer survivors
51. Association between depression during perimenopause and serum levels of follicle-stimulating hormone (FSH) and estradiol (E2)
52. Sexuality and menopause
53. Influence of menopause on serum lipids and lipoproteins
54. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
55. A randomised comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome
56. Transdermal oestrogen for treatment of severe postnatal depression
57. Longterm effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women
58. A quality of life perspective on who benefits from estradiol replacement therapy
59. The effect of exogenous oestrogens on depression in menopausal women
60. Psychological effects of continuation versus discontinuation of hormone replacement therapy by estrogen implants: A placebo-controlled study
61. Is oestrogen therapy effective in the treatment of menopausal depression?
62. Double blind study on the effect of estrogen on sleep, anxiety and depression in perimenopausal women: Preliminary results
63. Estrogen replacement in perimenopause-related depression: A preliminary report
64. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebo-controlled trial
65. The role of oestrogen replacement in the climacteric syndrome
66. Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives
67. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial
68. Fluoxetine efficacy in menopausal women with and without estrogen replacement
69. Prophylactic estrogen in recurrent postpartum affective disorder